A Registry of De Winter Symdrome of Single Center

ACS - Acute Coronary Syndrome Clinical Trial

Official title:

A Registry of De Winter Symdrome of Hainan General Hospital

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03707496
• Other study ID #: Reg001
• Status: Recruiting
• Start date: January 1, 2018
• Est. completion date: December 31, 2021

Study information

• Verified date: April 2021
• Source: Hainan People's Hospital
• Contact: Wang Liao, MD
• Phone: 13518827831
• Email: crain_lw[@]163.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

This registry started January 1,2018 to collect patients who diagnosed as De Winter Symdrome for the first time in Hainan General Hospital.All enrolled patients will receive 30 days followed-up.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 31, 2021
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Index ECG ST segment showed a 1- to 3-mm upsloping ST-segment depression at the J point in leads V1 to V6 that continued into tall, positive symmetrical T waves

• Received coronary angiography during hospitalization

Exclusion Criteria:

-No coronary angiography results was available during hospitalization

Related Conditions & MeSH terms

• ACS - Acute Coronary Syndrome
• Acute Coronary Syndrome

Locations

Country	Name	City	State
China	Hainan General Hospital	Haikou	Hainan

Sponsors (1)

Lead Sponsor	Collaborator
Hainan People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants with MACEs within 30 days	Number of participants with cardiac death,non-fatal myocardial infarction,stroke,heart failure in 30 days	30 days
Secondary	Number of participants with MACEs In-hospital	Number of participants with cardiac death,non-fatal myocardial infarction,stroke,heart failure in-hospital	throughout current hospitalization
Secondary	Number of Participants with MACEs within 7 days after admitted	Number of participants with cardiac death,non-fatal myocardial infarction,stroke,heart failure in 7 days	7 days after admitted